1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow GATA2 Deficiency: new trials by email Literature Review of GATA2 Deficiency trials Research Report on GATA2 Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant Nivolumab, Ipilimumab - Acute Myeloid Leukemia and Myelodysplastic Syndrome | Phase 1 | Terminated | Hackensack Meridian Health | 8 | 2019-03-08 | 2024-11-18 |
Bone Marrow Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Myelodysplastic Syndromes (1)
Ipilimumab (1) · Nivolumab (1)
Hackensack Meridian Health (1)
United States (1)
Andrew Pecora, MD (1) · James McCloskey, MD (1) · Jamie Koprivnikar, MD (1)